-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MBOVIlu9NzIkriId9NmieaWWHXoUKOQmVoAhZb1Rj5xtchLuubm4GmYxcePVdxLZ
 KKX1CY7npJ/35MbYx3chAg==

<SEC-DOCUMENT>0000929638-06-000158.txt : 20060411
<SEC-HEADER>0000929638-06-000158.hdr.sgml : 20060411
<ACCEPTANCE-DATETIME>20060411170323
ACCESSION NUMBER:		0000929638-06-000158
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041029
FILED AS OF DATE:		20060411
DATE AS OF CHANGE:		20060411

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUANTRX BIOMEDICAL CORP
		CENTRAL INDEX KEY:			0000820608
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330202574
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		321 NORRISTOWN ROAD
		STREET 2:		SUITE 230
		CITY:			AMBLER
		STATE:			PA
		ZIP:			19002
		BUSINESS PHONE:		2155404206

	MAIL ADDRESS:	
		STREET 1:		321 NORRISTOWN ROAD
		STREET 2:		SUITE 230
		CITY:			AMBLER
		STATE:			PA
		ZIP:			19002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AFEM MEDICAL CORP
		DATE OF NAME CHANGE:	19970722

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XTRAMEDICS INC /NV/
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Sherbrooke Partners, LLC
		CENTRAL INDEX KEY:			0001350007
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17119
		FILM NUMBER:		06754133

	BUSINESS ADDRESS:	
		STREET 1:		570 LEXINGTON AVENUE, FLOOR 3
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-980-2700

	MAIL ADDRESS:	
		STREET 1:		570 LEXINGTON AVENUE, FLOOR 3
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BALK MATTHEW
		CENTRAL INDEX KEY:			0001217674

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17119
		FILM NUMBER:		06754134

	BUSINESS ADDRESS:	
		STREET 1:		245 PARK AVE
		STREET 2:		44TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10167
		BUSINESS PHONE:		2128565701
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>sherbrooke3apr06_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2004-10-29</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000820608</issuerCik>
        <issuerName>QUANTRX BIOMEDICAL CORP</issuerName>
        <issuerTradingSymbol>QTXB.PK</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001217674</rptOwnerCik>
            <rptOwnerName>BALK MATTHEW</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>570 LEXINGTON AVENUE, FLOOR 3</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001350007</rptOwnerCik>
            <rptOwnerName>Sherbrooke Partners, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>570 LEXINGTON AVENUE, FLOOR 3</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5728009</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>see footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Of these shares, 4,508,009 are held by Sherbrooke Partners, LLC, of which Mr. Balk is the sole member, and 1,220,000 are held
 by Mr. Balk as custodian for his children.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Matthew Balk</signatureName>
        <signatureDate>2006-04-05</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Mathew Balk as managing member of Sherbrooke Partners, LLC</signatureName>
        <signatureDate>2006-04-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----